Back to results
US 2014/0194360 A1Published application
Use of antithrombin in extracorporeal membrane oxygenation
AssigneerEVO Biologics, Inc.
InventorsJohan Frieling, Simon Lowry
Life of this patent
Estimating the term…
Abstract
In one aspect, the disclosure provides methods of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation comprising administering antithrombin. In some embodiments, the antithrombin used in the methods disclosed herein is ATryn®.
Claims14
A method of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation, the method comprising:
- administering to a subject having extracorporeal membrane oxygenation a therapeutically effective amount of antithrombin to suppress blood clotting and/or prevent hemorrhage.
Dependencies are inferred from the claim text.